Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Genmab A/S has published its Articles of Association dated June 27, 2017. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm Contact: Rachel Curtis...
-
Selskabsvedtægter for Genmab A/S dateret den 27. juni 2017 er blevet offentliggjort. Selskabsvedtægterne er tilgængelige på Genmabs hjemmeside:...
-
Company Announcement Copenhagen, Denmark; June 27, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 163,164 shares as a consequence of the exercise of employee...
-
Company Announcement DARZALEX (daratumumab) approved by U.S. FDA in combination with pomalidomide and dexamethasone for patients with multiple myeloma who have received at least two prior...
-
Company Announcement Preliminary data shows responses achieved in 11 of 34 evaluable patients with cervical cancer treated with tisotumab vedotin Next steps in clinical development of...
-
Selskabsvedtægter for Genmab A/S dateret den 8. juni 2017 er blevet offentliggjort. Selskabsvedtægterne er tilgængelige på Genmabs hjemmeside:...
-
Genmab A/S has published its Articles of Association dated June 8, 2017. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm Contact: Rachel Curtis...
-
Company Announcement Copenhagen, Denmark; June 8, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that at a board meeting the board decided to grant 1,697 restricted stock units and...
-
Media Release Copenhagen, Denmark; May 30, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the Goldman Sachs...
-
Selskabsvedtægter for Genmab A/S dateret den 16. maj 2017 er blevet offentliggjort. Selskabsvedtægterne er tilgængelige på Genmabs hjemmeside:...